Balance Sheet Data
Bellicum Pharmaceuticals, Inc. (BLCM)
$0.2008
+0.00 (+0.40%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 93 | 91.03 | 35.49 | 46.16 | 21.84 | 270.27 | 1,289.82 | 6,155.56 | 29,376.84 | 140,198.11 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 2.30 | 0.30 | 0 | 0.21 | 0.21 | 3.24 | 15.48 | 73.90 | 352.66 | 1,683.04 |
| Account Receivables (%) | ||||||||||
| Inventories | -1.39 | 19.64 | 3.14 | 1.50 | -0.21 | 11.32 | 54.01 | 257.75 | 1,230.10 | 5,870.54 |
| Inventories (%) | ||||||||||
| Accounts Payable | 3.77 | 2.64 | 0.89 | 0.09 | 0.49 | 8.39 | 40.04 | 191.09 | 911.97 | 4,352.28 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -1.62 | -0.52 | -0.62 | -0.01 | -0.02 | -3.98 | -19.01 | -90.72 | -432.93 | -2,066.13 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.